Much attention has lately been given to DiMC due to its potency against various cancer cell lines in many cases, such as the ability to serve as an androgen receptor antagonist in human prostate cancer cells in vivo (Ramkumar et al., 2017; Hatamipour et al., 2018; Hatamipour et al., 2019). This evidence concerns the gene AR and prostate carcinoma.